Drug Quality and Security Act
GPTKB entity
Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_States_federal_law
|
| gptkbp:administeredBy |
gptkb:U.S._Food_and_Drug_Administration
|
| gptkbp:amendedBy |
gptkb:Federal_Food,_Drug,_and_Cosmetic_Act
|
| gptkbp:appliesTo |
pharmacies
pharmaceutical manufacturers wholesalers repackagers |
| gptkbp:citation |
21 U.S.C. § 301 et seq.
|
| gptkbp:dateEnacted |
November 27, 2013
|
| gptkbp:enactedBy |
gptkb:United_States_Congress
|
| https://www.w3.org/2000/01/rdf-schema#label |
Drug Quality and Security Act
|
| gptkbp:publicLawNumber |
Public Law 113-54
|
| gptkbp:purpose |
establish drug supply chain security
regulate compounding pharmacies |
| gptkbp:regulates |
outsourcing facilities
|
| gptkbp:replacedBy |
previous patchwork of state laws on drug compounding
|
| gptkbp:requires |
product identification
product verification product tracing licensing standards |
| gptkbp:response |
2012 New England Compounding Center meningitis outbreak
|
| gptkbp:shortName |
DQSA
|
| gptkbp:signedBy |
gptkb:Barack_Obama
|
| gptkbp:title |
Title I: Compounding Quality Act
Title II: Drug Supply Chain Security Act |
| gptkbp:bfsParent |
gptkb:Title_21_of_the_United_States_Code
|
| gptkbp:bfsLayer |
7
|